CELLULAR IMMUNITY DEFICIENCY NLM AIDSLINE Important note: Information in this article was accurate in 1981. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


CELLULAR IMMUNITY DEFICIENCY

Int Congr Ser; 502(part1):155-162 1980. Unique Identifier : AIDSLINE ICDB/81611714
Bendixen G; Copenhagen Univ. Hosp., Rigshospitalet, Tagensvej 18, 2200; Copenhagen, Denmark

Abstract: The etiology, diagnosis, monitoring, and therapy of cell-mediated immune deficiency (CMID) is discussed. CMID is a condition in which T-lymphocytes, which are developmentally and functionally dependent on the thymus, are absent or deficient at some level. CMID can be subclassified into two distinct types: the congenital types that result from inborn errors of the T-lymphocyte systems; and the acquired types which are quantitatively more important. Acquired CMID can result from suppression of the T-lymphocyte system due to infection, diseases of the hemopoietic system, malnutrition, or certain chronic diseases such as uremia or cancer. Virus infections, poisons, immunosuppressive drugs, and irradiation also can produce CMID. The pathogenesis of CMID is discussed. One major group of symptoms associated with CMID are those resulting from infection. Diagnostic tests to identify the presence of CMID are described. The importance of immunological monitoring in patients receiving immunosuppressive or cytostatic therapy is discussed. CMID treatment is based on the treatment and prevention of infection. (17 Refs)
Keywords: MEETING PAPER REVIEWKWDmeetingpaperreview
810630
M8160009

Copyright © 1981 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1981. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1981. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .